Xenon-Enhanced Cerebral Blood Flow at 28% Xenon Provides Uniquely Safe Access to Quantitative, Clinically Useful Cerebral Blood Flow Information: A Multicenter Study

References

1. 1.↵
   1. Latchaw RE,
   2. Yonas H,
   3. Pentheny SL,
   4. et al

   . Adverse reactions to xenon-enhanced CT cerebral blood flow determination. Radiology 1987;163:251–54

   PubMedWeb of Science
2. 2.↵
   1. Pindzola RR,
   2. Yonas H

   . The xenon-enhanced computed tomography cerebral blood flow method. Neurosurgery 1998;43:1488–92

   CrossRefPubMed
3. 3.↵
   1. Vazquez Anon V,
   2. Aymard A,
   3. Gobin YP,
   4. et al

   . Balloon occlusion of the internal carotid artery in 40 cases of giant intracavernous aneurysm: technical aspects, cerebral monitoring, and results. Neuroradiology 1992;34:245–51

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Mathis JM,
   2. Barr JD,
   3. Jungreis CA,
   4. et al

   . Temporary balloon test occlusion of the internal carotid artery: experience in 500 cases. AJNR Am J Neuroradiol 1995;16:749–54

   Abstract
5. 5.↵
   1. Gillard J,
   2. Graves M,
   3. Hatsukami T,
   4. et al.

   1. Carlson A,
   2. Yonas H

   . Monitoring carotid interventions with xenon CT. In: Gillard J, Graves M, Hatsukami T, et al., eds. Carotid Disease: The Role of Imaging in Diagnosis and Management. Cambridge, United Kingdom: Cambridge University Press; 2007:396–417
6. 6.↵
   1. Webster MW,
   2. Makaroun MS,
   3. Steed DL,
   4. et al

   . Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg 1995;21:338–44, discussion 344–45

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Kitahara T,
   2. Yamashita T,
   3. Kashiwagi S,
   4. et al

   . Hemodynamics of hypertensive putaminal hemorrhage evaluated by xenon-enhanced computed tomography and acetazolamide test. Acta Neurol Scand Suppl 1996;166:139–43

   PubMed
8. 8.↵
   1. Hughes RL,
   2. Yonas H,
   3. Gur D,
   4. et al

   . Cerebral blood flow determination within the first 8 hours of cerebral infarction using stable xenon-enhanced computed tomography. Stroke 1989;20:754–60

   Abstract/FREE Full Text
9. 9.↵
   1. Carlson AP,
   2. Yonas H

   . Radiographic assessment of vasospasm after aneurysmal subarachnoid hemorrhage: the physiological perspective. Neurol Res 2009;31:593–604

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Firlik KS,
    2. Firlik AD,
    3. Yonas H

    . Xenon-enhanced computed tomography in the management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Keio J Med 2000;49(suppl 1):A148–50

    CrossRefPubMed
11. 11.↵
    1. Fukui MB,
    2. Johnson DW,
    3. Yonas H,
    4. et al

    . Xe/CT cerebral blood flow evaluation of delayed symptomatic cerebral ischemia after subarachnoid hemorrhage. AJNR Am J Neuroradiol 1992;13:265–70

    Abstract/FREE Full Text
12. 12.↵
    1. Tarr RW,
    2. Johnson DW,
    3. Rutigliano M,
    4. et al

    . Use of acetazolamide-challenge xenon CT in the assessment of cerebral blood flow dynamics in patients with arteriovenous malformations. AJNR Am J Neuroradiol 1990;11:441–48

    Abstract/FREE Full Text
13. 13.↵
    1. Reigel MM,
    2. Hollier LH,
    3. Sundt TM Jr.,
    4. et al

    . Cerebral hyperperfusion syndrome: a cause of neurologic dysfunction after carotid endarterectomy. J Vasc Surg 1987;5:628–34

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Hlatky R,
    2. Contant CF,
    3. Diaz-Marchan P,
    4. et al

    . Significance of a reduced cerebral blood flow during the first 12 hours after traumatic brain injury. Neurocrit Care 2004;1:69–83

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Chieregato A,
    2. Noto A,
    3. Tanfani A,
    4. et al

    . Hyperemia beneath evacuated acute subdural hematoma is frequent and prolonged in patients with an unfavorable outcome: a Xe-computed tomographic study. Neurosurgery 2009;64:705–17, discussion 717–18

    CrossRefPubMed
16. 16.↵
    1. Latchaw RE,
    2. Yonas H,
    3. Darby JM,
    4. et al

    . Xenon/CT cerebral blood flow determination following cranial trauma. Acta Radiol Suppl 1986;369:370–73

    PubMed
17. 17.↵
    1. Maeder P,
    2. de Tribolet N

    . Xenon CT measurement of cerebral blood flow in hydrocephalus. Childs Nerv Syst 1995;11:388–91

    CrossRefPubMed
18. 18.↵
    1. Okuchi K,
    2. Nagata K,
    3. Otsuka H,
    4. et al

    . Regional cerebral blood flow after status epilepticus. Keio J Med 2000;49(suppl 1):A75–76

    PubMed
19. 19.↵
    1. Van Roost D,
    2. Hartmann A,
    3. Quade G

    . Changes of cerebral blood flow following dexamethasone treatment in brain tumour patients: a Xe/CT study. Acta Neurochir (Wien) 2001;143:37–43, discussion 43–44

    CrossRefPubMed
20. 20.↵
    1. Mori K,
    2. Teramoto K,
    3. Nagao M,
    4. et al

    . Regional cerebral blood flow in schizophrenia using stable xenon-enhanced computed tomography. Neuropsychobiology 1999;39:117–24

    CrossRefPubMed
21. 21.↵
    1. Goo HW,
    2. Chae EJ,
    3. Seo JB,
    4. et al

    . Xenon ventilation CT using a dual-source dual-energy technique: dynamic ventilation abnormality in a child with bronchial atresia. Pediatr Radiol 2008;38:1113–16

    CrossRefPubMed
22. 22.↵
    1. Gur D,
    2. Good WF,
    3. Herbert DL,
    4. et al

    . Blood flow mapping in the human liver by the Xe-CT method. J Comput Assist Tomogr 1985;9:447–50

    PubMedWeb of Science
23. 23.↵
    1. Yonas H,
    2. Smith HA,
    3. Durham SR,
    4. et al

    . Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993;79:483–89

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Wolfson SK Jr.,
    2. Clark J,
    3. Greenberg JH,
    4. et al

    . Xenon-enhanced computed tomography compared with [14C]iodoantipyrine for normal and low cerebral blood flow states in baboons. Stroke May 1990;21:751–57

    CrossRef
25. 25.↵
    1. Matsuda M,
    2. Lee H,
    3. Kuribayashi K,
    4. et al

    . Comparative study of regional cerebral blood flow values measured by Xe CT and Xe SPECT. Acta Neurol Scand Suppl 1996;166:13–16

    PubMed
26. 26.↵
    1. Rumboldt Z,
    2. Huda W,
    3. All JW

    . Review of portable CT with assessment of a dedicated head CT scanner. AJNR Am J Neuroradiol 2009;30:1630–36. Epub 2009 Aug 6

    Abstract/FREE Full Text
27. 27.↵
    1. Seifert H,
    2. Blass G,
    3. Leetz HK,
    4. et al

    . The radiation exposure of the patient from stable-xenon computed tomography. Br J Radiol 1995;68:301–05

    Abstract/FREE Full Text
28. 28.↵
    1. Gur D,
    2. Good WF,
    3. Wolfson SK Jr.,
    4. et al

    . In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography. Science 1982;215:1267–68

    Abstract/FREE Full Text
29. 29.↵
    1. Gur D,
    2. Yonas H,
    3. Jackson DL,
    4. et al

    . Simultaneous measurements of cerebral blood flow by the Xe-CT method and the microsphere method: a comparison. Invest Radiol 1985;20:672–77

    CrossRefPubMed
30. 30.↵
    1. Nariai T

    . Comparison of measurement between Xe/CT CBF and PET in cerebrovascular disease and brain tumor. Acta Neurol Scand Suppl 1996;166:10–12

    PubMed
31. 31.↵
    1. Valadka AB,
    2. Hlatky R,
    3. Furuya Y,
    4. et al

    . Brain tissue PO2: correlation with cerebral blood flow. Acta Neurochir Suppl 2002;81:299–301

    PubMedWeb of Science
32. 32.↵
    1. Preckel B,
    2. Weber NC,
    3. Sanders RD,
    4. et al

    . Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 2006;105:187–97

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Rossaint R,
    2. Reyle-Hahn M,
    3. Schulte Am Esch J,
    4. et al

    . Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003;98:6–13

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Sturnegk P,
    2. Mellergard P,
    3. Yonas H,
    4. et al

    . Potential use of quantitative bedside CBF monitoring (Xe-CT) for decision making in neurosurgical intensive care. Br J Neurosurg 2007;21:332–39

    CrossRefPubMed
35. 35.↵
    1. Chieregato A,
    2. Tanfani A,
    3. Compagnone C,
    4. et al

    . Global cerebral blood flow and CPP after severe head injury: a xenon-CT study. Intensive Care Med 2007;33:856–62

    CrossRefPubMed
36. 36.↵
    1. Behrens PF,
    2. Ostertag CB,
    3. Warnke PC

    . Regional cerebral blood flow in peritumoral brain edema during dexamethasone treatment: a xenon-enhanced computed tomographic study. Neurosurgery 1998;43:235–40, discussion 240–41

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Sesay M,
    2. Tanaka A,
    3. Dousset V,
    4. et al

    . Effects of premedication with oral hydroxyzine on patient motion during inhalation of 32% xenon for regional cerebral blood flow mapping. Keio J Med 2000;49(suppl 1):A41–44

    PubMed
38. 38.↵
    1. Yonas H,
    2. Grundy B,
    3. Gur D,
    4. et al

    . Side effects of xenon inhalation. J Comput Assist Tomogr 1981;5:591–92

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Yonas H,
    2. Pindzola RP,
    3. Johnson DW

    . Xenon/computed tomography cerebral blood flow and its use in clinical management. Neurosurg Clin N Am 1996;7:605–16

    PubMedWeb of Science
40. 40.↵
    1. Harrod CG,
    2. Bendok BR,
    3. Batjer HH

    . Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 2005;56:633–54

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Krol AL,
    2. Dzialowski I,
    3. Roy J,
    4. et al

    . Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography. Stroke 2007;38:2364–66

    Abstract/FREE Full Text
42. 42.↵
    1. Wang CL,
    2. Cohan RH,
    3. Ellis JH,
    4. et al

    . Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol 2008;191:409–15

    CrossRefPubMed
43. 43.↵
    1. Schaverien MV,
    2. Evison D,
    3. McCulley SJ

    . Management of large volume CT contrast medium extravasation injury: technical refinement and literature review. J Plast Reconstr Aesthet Surg 2008;61:562–65, discussion 565

    CrossRefPubMed
44. 44.↵
    1. Ray P,
    2. Riou B,
    3. Beigelman C,
    4. et al

    . Case reports of death after nonionic iodine contrast medium injection during spiral computed tomography scan performed for suspected pulmonary embolism. Am J Emerg Med 2006;24:497–99

    CrossRefPubMed
45. 45.↵
    1. Shellock FG,
    2. Spinazzi A

    . MRI safety update 2008. Part 1. MRI contrast agents and nephrogenic systemic fibrosis. AJR Am J Roentgenol 2008;191:1129–39

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Bellin MF,
    2. Van Der Molen AJ

    . Extracellular gadolinium-based contrast media: an overview. Eur J Radiol 2008;66:160–67

    CrossRefPubMed